Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial update evaluating pTVG-HP in combination with nivolumab for non-metastatic PSA-recurrent prostate cancer; results h…
-
FDA approval · 2023-12-04FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) from AbbVie, updating the product's label under a supplemental…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 [Phase 2]
Phase 2 trial update for hypofractionated focal lesion ablative microboost in prostate cancer (prostate adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating enzalutamide in combination with indomethacin for recurrent or metastatic hormone-resistant prostat…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: 68Ga-PSMA PET/CT in Prostate Cancer [Phase 3]
Phase 3 trial update on 68Ga-PSMA PET/CT in prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Prostate Cancer Patient Management With 18F-DCFPyL PET/CT [Phase 2, Phase 3]
Clinical trial update for prostate cancer exploring 18F-DCFPyL PET/CT imaging across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. [Phase 2, Phase 3]
Clinical trial update on genistein concentrated polysaccharide (GCP) for prostate cancer on active surveillance; completed Phase 2/Phase 3 t…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer [Phase 1, Phase 2]
A phase I/II clinical trial evaluating hydroxychloroquine in combination with itraconazole for biochemically recurrent prostate cancer has c…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating niraparib in combination therapies for metastatic castration-resistant prostate cancer; the study is active/not rec…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 [Phase 3]
Phase 3 trial evaluating short versus long-term androgen deprivation therapy in combination with salvage radiotherapy for prostate cancer; c…
-
FDA approval · 2023-11-17FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., resulting in updated labeling f…
-
FDA approval · 2023-11-16FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) from Astellas Pharma US, expanding its approved indication for prostate ca…
-
FDA approval · 2023-11-16FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc., updating the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy [Phase 1]
Phase 1 results from a study evaluating SBRT for locally recurrent prostate cancer after prior radiotherapy.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: 68Ga-PSMA-11 PET in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial update on 68Ga-PSMA-11 PET in prostate cancer, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery [Phase 3]
Phase 3 trial update for RADICALS evaluating radiotherapy and androgen deprivation after local surgery in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for neoadjuvant androgen deprivation with darolutamide and ipatasertib in localized high-risk prostate cancer; study t…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2]
Phase 2 clinical trial evaluating Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer; results posted …
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: BAY88-8223, Dose Finding Study in Patients With HRPC [Phase 2]
Phase 2 dose-finding trial of BAY88-8223 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) [Phase 1]
Phase 1 study of escalating doses of a vaccine-based immunotherapy regimen for prostate cancer (PrCa VBIR) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. [Phase 1, Phase 2]
First-in-man clinical study to evaluate safety and tolerability of an oncolytic adenovirus in prostate cancer patients (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel with or without thalidomide in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. [Phase 1]
Phase 1 trial evaluating safety, pharmacokinetics, and efficacy of Ipatasertib with Rucaparib in advanced breast, ovarian, and prostate canc…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluating antiandrogen therapy (abiraterone acetate) with or without neutron radiation therapy in castration-sensitive/pros…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery [Phase 4]
Phase 4 clinical trial evaluating perioperative intravenous lidocaine infusion in robotic-assisted urologic surgery has been terminated with…